Effect of pyridoxine (Vitamin-B(6)) supplementation on calciuria and oxaluria levels of some normal healthy persons and urinary stone patients

• Published in: Indian journal of clinical biochemistry Vol. 20; no. 2; pp. 166 - 169
• Main Authors: Rao, T V R K, Choudhary, V K
• Format: Journal Article
• Language: English
• Published: India Springer Nature B.V 01.07.2005; Springer India
• Subjects: Calcium (urinary); Calcium oxalate; Calciuria; Diet; Dietary supplements; Lithiasis; Oxalic acid; Pyridoxine; Supplements; Calciuria; Urolithiasis; Pyridoxine supplementation; Urinary stones; Oxaluria
• ISSN: 0970-1915; 0974-0422
• DOI: 10.1007/BF02867420

Effect of pyridoxine (Vitamin-B(6)) supplementation on calciuria and oxaluria levels of 20 normal healthy persons and 17 urinary stone patients has been studied. Mean 24 hr urinary calcium and oxalate levels of controls (healthy persons) and stone patients were estimated in presupplementation period and at every 20 days interval during supplementation. Stone patients were divided into two groups viz., mild hyperoxaluriacs and moderate hyperoxaluriacs, based on their pre-supplementation (base line) oxaluria levels. 60 days of pyridoxine supplementation, at the rate of 10 mg/day, resulted in a significant decrease (p<0.01 for mild hyperoxaluriacs and p<0.001 for moderate hyperoxaluriacs) in mean 24 hr urinary oxalate levels of urinary stone patients. The corresponding decrement in mean oxaluria level of controls was, however, only mild. The decrease of mean calciuria level of controls as well as stone patients, upon pyridoxine supplementation, were also found to be only mild and not significant. Utility of pyridoxine therapy in oxalate urolithiasis has been discussed in the light of results.